Skip to main content
. 2004;6(Suppl 4):S3–S8.

Figure 2.

Figure 2

Brachytherapy nomogram. Pretreatment nomogram predicting 5-year progression-free probability after transperineal interstitial prostatic brachytherapy using pretreatment (PreTx) prostate-specific antigen (PSA) levels, biopsy (Bx) Gleason sum, clinical stage, and the coadministration of external beam radiation therapy as predictor variables. Reprinted with permission from Kattan MW, et al.20